| ArteFill Manufacturer completes private placement |
|
|
|
| Written by David Castillo | |
|
Artes Medical, Inc, a medical aesthetics company, today announced that it has completed a financing with accredited investors raising approximately $2.4 million from a private placement of its common stock and related warrants. Empire Asset Management Company served as the placement agent for the transaction. The offering was fully subscribed.
Pursuant to the financing, Artes Medical issued approximately 2,735,817 shares of common stock at a purchase price of $0.73 per share. Artes also issued to the investors warrants to purchase an additional 1,367,916 shares of common stock at an exercise price of $0.75 per share. The warrants will be exercisable no sooner than six months following the closing of the private placement and will expire on March 26, 2014. In addition, Artes Medical issued 497,228 shares of common stock at a purchase price of $0.8125 per share and warrants to purchase 248,616 shares of common stock, at an exercise price of $0.75 per share, to investors who may be deemed to be affiliated with a member of our board of directors.
"This equity financing has been completed during very difficult and challenging times in our nation's capital markets and represents another step forward in our plan to commercialize our products and to seek out other strategic opportunities that are in the best interests of our stockholders," noted Christopher J. Reinhard, Executive Chairman of Artes Medical.
For services rendered as placement agent, Artes Medical paid Empire a cash fee equal to 8% of the aggregate proceeds raised in the financing and issued warrants to purchase up to 218,865 shares of common stock at an exercise price of $0.73 per share, up to 129,322 shares of common stock at an exercise price of $0.75 and up to 39,778 shares of common stock at an exercise price of $0.8125 per share.
The securities were offered to accredited investors in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended. The securities have not been registered under the Securities Act or any state securities laws and the securities may not be offered or sold absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. In connection with the financing, Artes has agreed, subject to certain terms and conditions, to provide piggyback registration rights with respect to the resale of the shares purchased and the shares issuable upon exercise of the warrants. This press release does not and will not constitute an offer to sell or the solicitation of an offer to buy shares or warrants. ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds. The unique microspheres in ArteFill are not absorbed by the body and therefore provide the first-of-its-kind permanent support for long-lasting wrinkle correction in one to two treatments.
|
| < Prev | Next > |
|---|
| Latest News |
|---|
| Popular |
|---|